Sector: Pharmaceuticals & Biotechnology

Small Cap

Phaarmasia Share Price

Q: What is the Market Capitalization of Phaarmasia Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Phaarmasia Ltd. is approximately ₹ 57 Cr.

Q: What are the PE and PB ratios for Phaarmasia Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Phaarmasia Ltd. is 3.2, and the Price-to-Book (PB) ratio is 2.1.

Q: What is the 52-Week High and Low for Phaarmasia Ltd.?

Over the past 52 weeks, the highest price reached by Phaarmasia Ltd. shares was ₹ 131.75, and the lowest price was ₹ 26.

Q: Who are the major shareholders of Phaarmasia Ltd.?

Significant shareholdings in Phaarmasia Ltd. typically include entities such as: Promoter Public Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Phaarmasia Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Phaarmasia Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Phaarmasia Ltd.

₹83.50

0.00(0.00%)

Trade Now

5th Jun 2026 | 2:58 PM

NSE :

Open Free Demat Account

Phaarmasia Performance

Price Movement

N/A

₹91.00

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹91.00

Low₹91.00

Open at₹91.00

Prev Close₹83.50

Volumes1

Avg Price₹91.00

Lower Circuit₹75.15

Upper Circuit₹91.85

Historical Performance

3M High₹114.00

3M Low₹69.00

1 Yr High₹131.75

1 Yr Low₹26.00

3 Yr High₹131.75

3 Yr Low₹22.11

5 Yr High₹131.75

5 Yr Low₹20.20

Phaarmasia Fundamentals

Market Cap

Low in industry

57 Cr.

PE Ratio (TTM)

Low in industry

3.20

Dividend Yield

Net Profit TTM

1205.7% incr over last year

17.58

Net Profit Growth

1205.7% incr over last year

17.58

PEG Ratio

Below industry Median

ROE

324.9% incr over last year

79.52

Operating Revenue TTM

47.21

Operating Revenue Growth

93.7% incr over last year

Book Value

Below industry Median

2.10

MFI

MFI is mid-range

48.74

RSI

RSI is mid-range

43.91

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

-0.32

Net Profit Qtr.

-0.27

Operating Revenue Qtr.

6.88

PB Ratio

2.10

Phaarmasia Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	7.73	16.05	16.55	6.87	5.43
Operating Expense	8.40	15.21	14.94	6.78	6.05
Operating Profit	-0.67	0.84	1.61	0.09	-0.62
Depreciation	0.04	0.06	0.05	0.06	0.08
Interest	0.18	0.02	0	0.03	0
Tax	0.17	3.64	-0.04	0.04	0.01
Net Profit	-0.70	16.27	1.74	0.27	-0.52

Phaarmasia Technicals

Phaarmasia Ltd. EMA & SMA

₹83.50

0.03 (0.04%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹81.7

Day EMA10 ₹82.1

Day EMA12 ₹82.6

Day EMA20 ₹84.9

Day EMA26 ₹86.2

Day EMA50 ₹89.2

Day EMA100 ₹87.2

Day EMA200 ₹76.2

Phaarmasia Support and Resistance

Resistance

First Resistance₹84.51

Second Resistance₹85.52

Third Resistance₹86.04

Support

First Support₹82.98

Second Support₹82.46

Third Support₹81.45

Technical Indicators

Day RSI43.91

Day MFI48.74

Day ADX11.13

Day Commodity Channel Index-19.80

William-44.10

Day MACD-3.64

Day MACD Signal Line-3.69

Day ATR2.95

Day ROC125153.03

Day ROC21-14.93

Phaarmasia Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	73.5	73.5	73.5	73.5	73.5	73.5
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	26.4	26.4	26.4	26.4	26.4	26.4

Phaarmasia Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	43	43	100.00%
Week	132	192	68.62%
1 Month	187	203	91.95%
6 Month	1.74 K	1.75 K	99.73%

Phaarmasia SWOT Analysis

Strengths19

Weakness8

Opportunity0

Threats0

Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with current TTM PE Ratio less than 3 Year, 5 Year and 10 Year PE

Strong Performer, Under Radar Stocks (DVM)

Undervalued Growth Stocks

Consistent high performing stocks over Five Years

Growth Stars: Strongest Annual EPS Performers

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Good Aggregate Candlestick Strength (total bullish - bearish candlesticks)

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Companies with Low Debt

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

Biggest Price Gainers from Open

Top Gainers

Phaarmasia Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Phaarmasia Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.
Price (₹)	₹118.15	₹45.25	₹557.95	₹216.05	₹268.50	₹41.43
% Change	N/A	0.00%	2.34%	0.00%	0.00%	0.00%
Revenue TTM (₹ Cr)	-	-	-	-	-	₹1.27
Net Profit TTM (₹ Cr)	-	-	-	-	-	₹-0.25
PE TTM	58.50	15.30	-	14.60	38.40	-98.10
1 Year Return	-11.87		39.08			820.67
ROCE	-	-	3.56	-	-	-

Similar Stocks

VIVIMEDLAB

Vivimed Labs Ltd.

₹ 6.49

+1.56%

CURIS

Curis Lifesciences Ltd.

₹ 112.00

+0.00%

APPL

Aptus Pharma Ltd.

₹ 229.65

+0.00%

AMANTA

Amanta Healthcare Ltd.

₹ 132.12

-1.03%

AHCL

Anlon Healthcare Ltd.

₹ 13.74

-1.72%

MEDISTEP

Medistep Healthcare Ltd.

₹ 19.55

+0.00%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 84.00

+0.00%

APL

Asston Pharmaceuticals Ltd.

₹ 70.00

+1.95%

INFLUX

Influx Healthtech Ltd.

₹ 238.00

-0.42%

MEDIORG

Medicamen Organics Ltd.

₹ 21.00

+0.00%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 546.00

-1.10%

ASTONEALAB

Astonea Labs Ltd.

₹ 255.15

-4.76%

AMWILL

Amwill Health Care Ltd.

₹ 40.57

-2.00%

SENORES

Senores Pharmaceuticals Ltd.

₹ 1035.00

+0.03%

INNOVACAP

Innova Captab Ltd.

₹ 886.20

+2.16%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 73.00

-0.21%

SHELTER

Shelter Pharma Ltd.

₹ 30.15

-0.26%

TLL

Trident Lifeline Ltd.

₹ 242.60

-0.16%

DPL

Dipna Pharmachem Ltd.

₹ 7.63

+5.97%

ACHYUT

Achyut Healthcare Ltd.

₹ 6.68

+0.75%

SIGACHI

Sigachi Industries Ltd.

₹ 21.28

-0.88%

WINDLAS

Windlas Biotech Ltd.

₹ 818.00

+0.47%

VINEETLAB

Vineet Laboratories Ltd.

₹ 33.20

-4.52%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 43.50

+0.00%

FAQ's on PHRMASI

What is the Market Capitalization of Phaarmasia Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Phaarmasia Ltd. is approximately ₹ 57 Cr.

What are the PE and PB ratios for Phaarmasia Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Phaarmasia Ltd. is 3.2, and the Price-to-Book (PB) ratio is 2.1.

What is the 52-Week High and Low for Phaarmasia Ltd.?

Over the past 52 weeks, the highest price reached by Phaarmasia Ltd. shares was ₹ 131.75, and the lowest price was ₹ 26.

Who are the major shareholders of Phaarmasia Ltd.?

Significant shareholdings in Phaarmasia Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Phaarmasia Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Phaarmasia Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy